To include your compound in the COVID-19 Resource Center, submit it here.

Lundbeck snags PD play Prexton

H. Lundbeck A/S (CSE:LUN) will acquire Prexton Therapeutics B.V. (Oss, the Netherlands) for €100 million

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE